Hopwood Financial Services Inc. acquired a new stake in shares of KKR & Co. Inc. (NYSE:KKR – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 500 shares of the asset manager’s stock, valued at approximately $74,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Farmers & Merchants Investments Inc. raised its stake in KKR & Co. Inc. by 17.8% during the 4th quarter. Farmers & Merchants Investments Inc. now owns 430 shares of the asset manager’s stock valued at $64,000 after acquiring an additional 65 shares during the last quarter. Oppenheimer Asset Management Inc. raised its stake in KKR & Co. Inc. by 0.4% during the 4th quarter. Oppenheimer Asset Management Inc. now owns 16,427 shares of the asset manager’s stock valued at $2,430,000 after acquiring an additional 69 shares during the last quarter. Ballentine Partners LLC raised its stake in KKR & Co. Inc. by 1.2% during the 4th quarter. Ballentine Partners LLC now owns 5,721 shares of the asset manager’s stock valued at $846,000 after acquiring an additional 70 shares during the last quarter. Parkside Financial Bank & Trust raised its stake in KKR & Co. Inc. by 5.7% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,289 shares of the asset manager’s stock valued at $191,000 after acquiring an additional 70 shares during the last quarter. Finally, Wealthcare Advisory Partners LLC raised its stake in KKR & Co. Inc. by 0.7% during the 4th quarter. Wealthcare Advisory Partners LLC now owns 10,974 shares of the asset manager’s stock valued at $1,623,000 after acquiring an additional 73 shares during the last quarter. 76.26% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research firms have commented on KKR. Keefe, Bruyette & Woods reduced their price objective on KKR & Co. Inc. from $170.00 to $168.00 and set an “outperform” rating for the company in a research note on Monday, January 13th. The Goldman Sachs Group increased their target price on KKR & Co. Inc. from $160.00 to $177.00 and gave the stock a “buy” rating in a research note on Tuesday, November 19th. Morgan Stanley cut their target price on KKR & Co. Inc. from $157.00 to $156.00 and set an “equal weight” rating for the company in a research note on Thursday, February 6th. Barclays cut their target price on KKR & Co. Inc. from $185.00 to $181.00 and set an “overweight” rating for the company in a research note on Wednesday, February 5th. Finally, HSBC downgraded KKR & Co. Inc. from a “buy” rating to a “hold” rating and increased their target price for the stock from $153.00 to $173.00 in a research note on Thursday, January 30th. One analyst has rated the stock with a sell rating, four have given a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, KKR & Co. Inc. has a consensus rating of “Moderate Buy” and a consensus price target of $161.43.
KKR & Co. Inc. Stock Performance
KKR opened at $114.23 on Thursday. The stock has a market cap of $101.46 billion, a P/E ratio of 34.30, a P/E/G ratio of 1.00 and a beta of 1.72. The company has a debt-to-equity ratio of 0.82, a current ratio of 0.07 and a quick ratio of 0.07. The stock’s 50 day simple moving average is $143.74 and its 200 day simple moving average is $141.84. KKR & Co. Inc. has a 1-year low of $91.92 and a 1-year high of $170.40.
KKR & Co. Inc. Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were issued a $0.175 dividend. This represents a $0.70 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date of this dividend was Friday, February 14th. KKR & Co. Inc.’s dividend payout ratio is currently 21.02%.
Insider Buying and Selling at KKR & Co. Inc.
In other KKR & Co. Inc. news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $32.96, for a total transaction of $197,760,000.00. Following the sale, the insider now owns 19,260,971 shares in the company, valued at approximately $634,841,604.16. This represents a 23.75 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 39.34% of the stock is owned by insiders.
KKR & Co. Inc. Company Profile
KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.
Featured Articles
- Five stocks we like better than KKR & Co. Inc.
- What Are Dividend Challengers?
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- How to Use the MarketBeat Stock Screener
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- How to Invest in Blue Chip Stocks
- Why Energy Transfer Belongs on Your Watchlist
Want to see what other hedge funds are holding KKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for KKR & Co. Inc. (NYSE:KKR – Free Report).
Receive News & Ratings for KKR & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KKR & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.